TERM, TERMINATION, AND MODIFICATION OF RIGHTS. The NIH reserves the right according to 35 U.S.C. § 209(d)(3) to terminate or modify this Agreement if it is determined that this action is necessary to meet the requirements for public use specified by federal regulations issued after the date of the license and these requirements are not reasonably satisfied by the Licensee.
Appears in 3 contracts
Sources: Exclusive License Agreement, Exclusive License Agreement, Exclusive License Agreement (Juno Therapeutics, Inc.)